vernakalant
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
BACKGROUND
Postoperative, new-onset atrial fibrillation (POAF) is one of the most common complications after cardiosurgical…
INTRODUCTION
Options for a pharmacological cardioversion (CV) of short-duration atrial fibrillation (AF) in patients with a…
Atrial fibrillation (AF) is the most common sustained arrhythmia. Cardioversion is considered one of the best treatments for…
AIMS
About one-third of patients with mild dyssynchronous heart failure suffer from atrial fibrillation (AF). Drugs that convert…
Atrial fibrillation is the most common cardiac arrhythmia and is associated with increased mortality and morbidity. Conversion to…
Conversion of recent onset atrial fibrillation (AF) to sinus rhythm with antiarrhythmic drugs reduces the risk of hemodynamic…
Vernakalant is a novel antiarrhythmic agent that has demonstrated clinical efficacy for the treatment of atrial fibrillation…
A series of in vivo experiments were conducted to compare the hemodynamic actions of vernakalant (a novel, relatively atrial…
The treatment and prevention of atrial fibrillation (AF) remains a significant unmet medical need. Existing therapies that…
ZusammenfassungKardiale Arrhythmien stellen eine häufige Komplikation in der perioperativen Phase dar. Die in der Literatur zu…